Implementing a Scheduled, Cost-Effective, Non-Opioid Analgesic Order Set for Post-Cesarean Patients to Reduce Opioid Requirements (1 Class A CE with .75 Pharm)

Start Course Now

Class A Credits: 1.00

Pharmacology Credits: .75

Format: Video

Course Launch Date: 11/5/20

Course Expires: 11/6/23

There were greater than 1.4 million Cesarean sections reported in 2016 and is one of the most frequently performed surgical procedures in the United States. After a Cesarean delivery, most providers prescribe opioids for pain relief. If this practice continues, one in 300 opioid-naive post-Cesarean patients is predicted to become a regular opioid user. This quality improvement project will implement a non-opioid analgesic order set to post-operative post-Cesarean patients. The multi-modal order set will consist of dexamethasone 4 mg IV, ketorolac 15 mg IV, and acetaminophen PO and will be given every six hours for the first 24 hours after the Cesarean. Pain scores will be collected before each order set administration and recorded for analysis at the conclusion of the initiative. Cost comparison will be performed to determine if there are significant costs related to treating the side effects of opioid administration in the post-Cesarean patient. The results and conclusions will be presented in detail after data analysis.

The American Association of Nurse Anesthetists is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • Describe the phyciologic effects and co-existing complications of opioid use in the post-Cesarean patient population.
  • Identify non-opioid approaches for post-Cesarean pain management and formulate a multi-modal, non-opioid analgesic combinations to address their post-cesarean pain.
  • Identify gaps in pain control coverage in scheduled non-opioid pain regimen by analyzing pain scores at 0, 6, 12, 18, 24 hours and explore alternatives to opioids during pain control gaps.

Gina Willaford,


Virgina Muckler,